🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical study is to compare the study drug, axicabtagene ...
Status
Active Not Recruiting
Location
University of Alabama Hospital
Start Date
2023-02-10
Trial ID
NCT05605899
This is an open label, non-randomized, phase 1 study of anti-CD19 CAR-T cel...
Status
Recruiting
Location
Huntsman Cancer Institute
Start Date
2024-02-20
Trial ID
NCT06227026
Treatments Being Tested
This phase I trial studies the side effects and best dose of CD19/CD20 chim...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2019-10-04
Trial ID
NCT04007029
Treatments Being Tested
The goal of this clinical study is test how well the study drug, axicabtage...
Status
Active Not Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2022-09-22
Trial ID
NCT05371093
This is an investigator-initiated trial to evaluate the safety and efficacy...
Status
Unknown
Location
Shanghai ChangZheng hospital
Start Date
2024-04-20
Trial ID
NCT06373081
Treatments Being Tested
Phase IIa study to estimate the efficacy of a single infusion of autologous...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2014-02-05
Trial ID
NCT02030834
Treatments Being Tested
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childre...
Status
Recruiting
Location
National University of Medical Sciences, Clinical Trial Unit
Start Date
2026-06-01
Trial ID
NCT07695012
Treatments Being Tested
Background: Chronic lymphocytic leukemia (CLL),small lymphocytic lymphoma ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2024-09-03
Trial ID
NCT06364423
Treatments Being Tested
The primary objective of this study is to estimate the efficacy of axicabta...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2019-11-05
Trial ID
NCT04002401
Treatments Being Tested
This is an open-label, four-cohort, phase 2 study to determine the efficacy...
Status
Recruiting
Location
Children's Hospital of Philadelphia
Start Date
2020-03-12
Trial ID
NCT04276870
Treatments Being Tested